Page last updated: 2024-08-23

ilmofosine and Carcinoma

ilmofosine has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arthur, G; Bittman, R; Byun, HS; Reddy, KC; Samadder, P1
Berdel, WE; Bicker, U; Boerner, D; Fromm, M; Heim, ME; Herrmann, DB; Neumann, HA1

Trials

1 trial(s) available for ilmofosine and Carcinoma

ArticleYear
Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients.
    Lipids, 1987, Volume: 22, Issue:11

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers

1987

Other Studies

1 other study(ies) available for ilmofosine and Carcinoma

ArticleYear
Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: Antineoplastic Agents; Carcinoma; Cell Division; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Phosphatidylcholines; Phospholipid Ethers; Stereoisomerism; Tumor Cells, Cultured

1997